| 1.23 0 (0%) | 10-04 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.53 | 1-year : | 1.63 |
| Resists | First : | 1.31 | Second : | 1.39 |
| Pivot price | 1.25  |
|||
| Supports | First : | 1.18 | Second : | 0.98 |
| MAs | MA(5) : | 1.22 |
MA(20) : | 1.27 |
| MA(100) : | 1.33 |
MA(250) : | 1.95 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 14.2 |
D(3) : | 9.7 |
| RSI | RSI(14): 44.6 |
|||
| 52-week | High : | 10.35 | Low : | 0.92 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CMND ] has closed above bottom band by 37.8%. Bollinger Bands are 62% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.24 - 1.25 | 1.25 - 1.26 |
| Low: | 1.19 - 1.2 | 1.2 - 1.21 |
| Close: | 1.22 - 1.23 | 1.23 - 1.24 |
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Mon, 16 Sep 2024
SciSparc-Clearmind Medicine Collaboration Announces the - GlobeNewswire
Fri, 06 Sep 2024
Clearmind Medicine files patent for novel MDMA therapy - Investing.com
Thu, 22 Aug 2024
Clearmind receives patent for drug to treat binge behavior - Green Market Report
Tue, 16 Jul 2024
FDA clears Clearmind's drug trial for alcohol disorder - Investing.com
Fri, 28 Jun 2024
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher - Benzinga
Tue, 07 May 2024
Why Clearmind Medicine Stock Is Moving Higher - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 4 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 4 (%) |
| Shares Short | 232 (K) |
| Shares Short P.Month | 223 (K) |
| EPS | -1.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.87 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -58 % |
| Return on Equity (ttm) | -267.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.45 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -1 |
| PEG Ratio | 0 |
| Price to Book value | 1.41 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|